Rockefeller Capital Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-30
Closed -$109 – 4999
2026
Q2
$109 Hold
30
– – ﹤0.01% 4686
2026
Q1
$145 Hold
30
– – ﹤0.01% 4620
2025
Q4
$219 Hold
30
– – ﹤0.01% 4584
2025
Q3
$492 Buy
+30
New +$592 ﹤0.01% 4270
2023
Q1
– Sell
-62
Closed -$3K – 3952
2022
Q4
$3K Hold
62
– – ﹤0.01% 3503
2022
Q3
$3K Hold
62
– – ﹤0.01% 3524
2022
Q2
$3K Hold
62
– – ﹤0.01% 3712
2022
Q1
$3K Hold
62
– – ﹤0.01% 3538
2021
Q4
$4K Buy
+62
New +$5.38K ﹤0.01% 3385

Other funds holding QNTM

Rockefeller Capital Management's QNTM Position: Q3 2026 in Review

Rockefeller Capital Management sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2026, closing a stake of 30 shares — an estimated $109 sold.

Rockefeller Capital Management first reported a position in QNTM in Q4 2021 and held it in 9 quarters. The position peaked at $4K in Q4 2021. 22 funds tracked by Wall St. Rank hold QNTM as of Q3 2026.

  • Rockefeller Capital Management reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 30 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2026, an estimated $109.
  • Rockefeller Capital Management first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2021 and held it in 9 quarters.
  • Rockefeller Capital Management's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $4K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.